Gossamer Historical Balance Sheet

GOSS Stock

USD 0.70 0.04 6.06%

Trend analysis of Gossamer Bio balance sheet accounts such as Other Current Liabilities of 24.6 M or Total Current Liabilities of 32.7 M provides information on Gossamer Bio's total assets, liabilities, and equity, which is the actual value of Gossamer Bio to its prevalent stockholders. By breaking down trends over time using Gossamer Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Gossamer Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Gossamer Bio is a good buy for the upcoming year.

Gossamer Bio Inventory

(164,220)

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gossamer Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.

About Gossamer Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Gossamer Bio at a specified time, usually calculated after every quarter, six months, or one year. Gossamer Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Gossamer Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Gossamer currently owns. An asset can also be divided into two categories, current and non-current.

Gossamer Bio Balance Sheet Chart

At this time, Gossamer Bio's Net Working Capital is comparatively stable compared to the past year. Property Plant And Equipment Net is likely to gain to about 8.1 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 134 M in 2024.

Total Assets Short Long Term Debt Total Accounts Payable Non Current Assets Total Retained Earnings Total Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Gossamer Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Gossamer Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Accounts Payable

An accounting item on the balance sheet that represents Gossamer Bio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Gossamer Bio are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Retained Earnings Total Equity

The portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt.

Most accounts from Gossamer Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Gossamer Bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gossamer Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.At this time, Gossamer Bio's Net Working Capital is comparatively stable compared to the past year. Property Plant And Equipment Net is likely to gain to about 8.1 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 134 M in 2024.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	185.2M	225.7M	212.5M	134.0M
Total Assets	343.7M	272.5M	311.9M	293.4M

Short Long Term Debt Total Total Assets

Gossamer Bio balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Total Liab	Total Current Assets	Other Liab	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Net Invested Capital	Net Working Capital	Property Plant And Equipment Net	Other Assets	Net Receivables
Total Assets		0.78	0.93	0.9	-0.6	0.69	-0.27	-0.72	0.83	0.81	0.77	1.0	0.65	0.91	0.7	0.76	1.0	0.92	0.85	0.88	0.57	0.88	1.0	0.89	-0.84	-0.03
Short Long Term Debt Total	0.78		0.87	0.93	-0.67	0.31	0.18	-0.93	0.8	0.58	1.0	0.78	0.79	0.83	0.72	0.78	0.78	0.83	0.95	0.93	0.9	0.76	0.76	0.61	-0.91	-0.52
Other Current Liab	0.93	0.87		0.98	-0.67	0.52	0.03	-0.85	0.71	0.6	0.85	0.93	0.74	0.95	0.74	0.81	0.93	0.96	0.93	0.94	0.65	0.82	0.91	0.79	-0.91	-0.08
Total Current Liabilities	0.9	0.93	0.98		-0.64	0.45	0.12	-0.91	0.76	0.57	0.92	0.9	0.8	0.94	0.75	0.82	0.9	0.94	0.97	0.98	0.74	0.82	0.88	0.73	-0.94	-0.2
Total Stockholder Equity	-0.6	-0.67	-0.67	-0.64		-0.44	0.21	0.46	-0.36	-0.63	-0.67	-0.6	-0.16	-0.51	-0.48	-0.52	-0.6	-0.52	-0.64	-0.66	-0.4	-0.58	-0.57	-0.69	0.52	0.16
Net Tangible Assets	0.69	0.31	0.52	0.45	-0.44		-0.53	-0.21	0.46	0.72	0.31	0.69	0.1	0.38	-0.01	0.06	0.69	0.39	0.5	0.47	0.06	0.83	0.69	0.9	-0.47	0.41
Net Debt	-0.27	0.18	0.03	0.12	0.21	-0.53		-0.43	-0.23	-0.68	0.19	-0.27	0.48	0.06	-0.01	0.01	-0.26	0.06	0.16	0.11	0.4	-0.16	-0.28	-0.4	-0.26	-0.3
Retained Earnings	-0.72	-0.93	-0.85	-0.91	0.46	-0.21	-0.43		-0.7	-0.35	-0.93	-0.72	-0.94	-0.86	-0.67	-0.73	-0.72	-0.86	-0.92	-0.9	-0.92	-0.71	-0.71	-0.51	0.96	0.45
Accounts Payable	0.83	0.8	0.71	0.76	-0.36	0.46	-0.23	-0.7		0.78	0.8	0.84	0.68	0.75	0.68	0.72	0.84	0.76	0.77	0.75	0.73	0.75	0.83	0.6	-0.74	-0.43
Cash	0.81	0.58	0.6	0.57	-0.63	0.72	-0.68	-0.35	0.78		0.57	0.81	0.22	0.56	0.5	0.53	0.81	0.57	0.56	0.6	0.37	0.74	0.81	0.82	-0.5	-0.14
Long Term Debt	0.77	1.0	0.85	0.92	-0.67	0.31	0.19	-0.93	0.8	0.57		0.77	0.78	0.81	0.71	0.76	0.77	0.81	0.95	0.92	0.91	0.76	0.74	0.6	-0.91	-0.54
Cash And Short Term Investments	1.0	0.78	0.93	0.9	-0.6	0.69	-0.27	-0.72	0.84	0.81	0.77		0.65	0.91	0.7	0.76	1.0	0.92	0.85	0.88	0.57	0.88	1.0	0.89	-0.84	-0.03
Common Stock Shares Outstanding	0.65	0.79	0.74	0.8	-0.16	0.1	0.48	-0.94	0.68	0.22	0.78	0.65		0.84	0.66	0.71	0.66	0.84	0.78	0.78	0.86	0.58	0.65	0.36	-0.88	-0.41
Long Term Debt Total	0.91	0.83	0.95	0.94	-0.51	0.38	0.06	-0.86	0.75	0.56	0.81	0.91	0.84		0.84	0.89	0.91	1.0	0.85	0.9	0.69	0.72	0.91	0.68	-0.88	-0.16
Non Current Liabilities Total	0.7	0.72	0.74	0.75	-0.48	-0.01	-0.01	-0.67	0.68	0.5	0.71	0.7	0.66	0.84		0.99	0.7	0.85	0.61	0.7	0.62	0.35	0.69	0.36	-0.58	-0.4
Total Liab	0.76	0.78	0.81	0.82	-0.52	0.06	0.01	-0.73	0.72	0.53	0.76	0.76	0.71	0.89	0.99		0.76	0.89	0.69	0.77	0.66	0.44	0.74	0.43	-0.66	-0.38
Total Current Assets	1.0	0.78	0.93	0.9	-0.6	0.69	-0.26	-0.72	0.84	0.81	0.77	1.0	0.66	0.91	0.7	0.76		0.92	0.85	0.88	0.57	0.88	1.0	0.88	-0.84	-0.04
Other Liab	0.92	0.83	0.96	0.94	-0.52	0.39	0.06	-0.86	0.76	0.57	0.81	0.92	0.84	1.0	0.85	0.89	0.92		0.86	0.91	0.69	0.73	0.91	0.69	-0.88	-0.16
Capital Surpluse	0.85	0.95	0.93	0.97	-0.64	0.5	0.16	-0.92	0.77	0.56	0.95	0.85	0.78	0.85	0.61	0.69	0.85	0.86		0.96	0.8	0.88	0.82	0.72	-0.96	-0.27
Other Current Assets	0.88	0.93	0.94	0.98	-0.66	0.47	0.11	-0.9	0.75	0.6	0.92	0.88	0.78	0.9	0.7	0.77	0.88	0.91	0.96		0.76	0.84	0.86	0.75	-0.94	-0.23
Other Stockholder Equity	0.57	0.9	0.65	0.74	-0.4	0.06	0.4	-0.92	0.73	0.37	0.91	0.57	0.86	0.69	0.62	0.66	0.57	0.69	0.8	0.76		0.59	0.56	0.35	-0.84	-0.75
Net Invested Capital	0.88	0.76	0.82	0.82	-0.58	0.83	-0.16	-0.71	0.75	0.74	0.76	0.88	0.58	0.72	0.35	0.44	0.88	0.73	0.88	0.84	0.59		0.88	0.92	-0.87	-0.03
Net Working Capital	1.0	0.76	0.91	0.88	-0.57	0.69	-0.28	-0.71	0.83	0.81	0.74	1.0	0.65	0.91	0.69	0.74	1.0	0.91	0.82	0.86	0.56	0.88		0.89	-0.83	-0.03
Property Plant And Equipment Net	0.89	0.61	0.79	0.73	-0.69	0.9	-0.4	-0.51	0.6	0.82	0.6	0.89	0.36	0.68	0.36	0.43	0.88	0.69	0.72	0.75	0.35	0.92	0.89		-0.71	0.19
Other Assets	-0.84	-0.91	-0.91	-0.94	0.52	-0.47	-0.26	0.96	-0.74	-0.5	-0.91	-0.84	-0.88	-0.88	-0.58	-0.66	-0.84	-0.88	-0.96	-0.94	-0.84	-0.87	-0.83	-0.71		0.28
Net Receivables	-0.03	-0.52	-0.08	-0.2	0.16	0.41	-0.3	0.45	-0.43	-0.14	-0.54	-0.03	-0.41	-0.16	-0.4	-0.38	-0.04	-0.16	-0.27	-0.23	-0.75	-0.03	-0.03	0.19	0.28

Click cells to compare fundamentals

Gossamer Bio Account Relationship Matchups

Gossamer Bio balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	426.6M	539.4M	343.7M	272.5M	311.9M	293.4M
Other Current Liab	33.6M	27.5M	33.7M	33.2M	31.2M	24.6M
Total Current Liabilities	36.9M	38.7M	39.9M	49.2M	51.6M	32.7M
Total Stockholder Equity	(334.2M)	(577.5M)	(811.5M)	(1.0B)	62.8M	65.9M
Net Tangible Assets	352.5M	320.7M	121.5M	12.1M	13.9M	13.2M
Net Debt	(95.5M)	(302.3M)	1.8M	113.8M	180.4M	189.4M
Retained Earnings	(334.2M)	(577.5M)	(811.5M)	(1.0B)	(1.2B)	(1.2B)
Accounts Payable	956K	7.5M	3.2M	1.5M	5.5M	2.9M
Cash	135.1M	486.1M	183.4M	112.0M	32.1M	30.5M
Non Current Assets Total	17.3M	17.1M	11.9M	10.6M	5.4M	9.6M
Non Currrent Assets Other	1.6M	1.0M	1.1M	680K	618K	923.7K
Cash And Short Term Investments	401.8M	512.6M	325.2M	255.7M	296.4M	277.9M
Common Stock Shares Outstanding	54.7M	68.5M	74.8M	84.6M	152.6M	160.3M
Short Term Investments	266.7M	26.6M	141.8M	143.7M	264.3M	132.9M
Liabilities And Stockholders Equity	(260.1M)	(358.8M)	(589.3M)	(771.9M)	311.9M	327.5M
Non Current Liabilities Total	37.2M	180.1M	182.3M	211.1M	197.5M	158.6M
Total Liab	74.1M	218.7M	222.2M	260.4M	249.1M	191.3M
Total Current Assets	409.3M	522.3M	331.8M	261.9M	306.5M	283.8M
Capital Surpluse	686.4M	897.6M	932.9M	1.0B	1.2B	659.2M
Other Current Assets	7.5M	9.7M	6.6M	12.4M	10.1M	7.8M
Other Stockholder Equity	(426.9M)	897.6M	932.9M	1.0B	1.3B	1.3B
Net Invested Capital	380.9M	493.1M	300.6M	231.4M	271.8M	244.7M
Net Working Capital	372.4M	483.7M	291.9M	212.7M	254.9M	287.0M
Property Plant And Equipment Net	15.7M	16.1M	10.8M	9.9M	4.8M	8.1M
Other Assets	1.6M	1.0M	1.1M	680K	1.0	0.95
Property Plant And Equipment Gross	15.7M	16.1M	15.1M	16.0M	10.2M	14.0M
Accumulated Other Comprehensive Income	258K	599K	45K	(574K)	(350K)	(332.5K)
Property Plant Equipment	15.7M	5.5M	5.3M	4.0M	3.6M	5.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Gossamer Stock Analysis

When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Gossamer Historical Balance Sheet

Gossamer Bio Inventory

(164,220)

About Gossamer Balance Sheet Analysis

Gossamer Bio Balance Sheet Chart

Total Assets

Accounts Payable

Non Current Assets Total

Retained Earnings Total Equity

Gossamer Bio balance sheet Correlations

Gossamer Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Gossamer Bio balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Gossamer Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Long Term Debt	+ 1.0	Short Long Term Debt Total
Total Current Assets	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Cash And Short Term Investments

Other Assets	- 0.96	Capital Surpluse
Other Assets	- 0.94	Other Current Assets
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Other Assets	- 0.94	Total Current Liabilities
Long Term Debt	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Short Long Term Debt Total